botensilimab,balstilimab
agenus
 mss does not mean that they cannot benefit from immunotherapy. you are right. markers that predict immune response in mss tumors are much more important than msh tumors.we must define the group that will benefit from io, even if it is small. (pole mut, mutyh mut ) high tmb group
T?bbi Onkoloji Uzman?, Medical Oncologist MD, Acibadem Hospital Adana, Turkey. Nextgene Oncogenomics Solutions